← Eichor
Study identifier: NCT06303752 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Tissue Therapy of Transsphincteric Anal Fistula

Condition: Anal Fistula  ·  Sponsor: University of Southern Denmark

PhasePhase 1/Phase 2
Planned participants75
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This clinical study aims to evaluate the outcome of the treatment of complex perianal fistulas (PAF) by the combination of minimal surgical debridement with regenerative cellular therapeutics.

This description comes directly from the study's public registry record.

Talk to the study team

Karam M Sørensen, Ph.D  ·  +4565415190  ·  ouh.a.forskningsenheden@rsyd.dk

Tina D Hansen  ·  +4565415190  ·  ouh.a.forskningsenheden@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Odense University HospitalOdense, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06303752